The news: The FDA’s Office of Prescription Drug Promotion (OPDP) recently called out Merz Pharma for making misleading claims about one of its products, Xeomin, in an Instagram ad.

• Xeomin is a prescription injectable medication used to treat wrinkles.
• The social media post in question was made by Merz on the Xeomin Aesthetics Instagram account, and shared by celebrity interior designer Nate Berkus via a paid brand partnership.